Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus

Arch Ophthalmol. 2005 Sep;123(9):1273-5. doi: 10.1001/archopht.123.9.1273.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Fluorescein Angiography
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Macular Edema / chemically induced*
  • Macular Edema / physiopathology
  • Male
  • Middle Aged
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Vision Disorders / chemically induced*
  • Vision Disorders / physiopathology

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone